---
title: The Untapped Therapeutic Frontier
description: You've explored less than 1% of medicine. The other 99% is where the cures are.
published: true
tags:
  - problem
  - drug-discovery
  - chemical-space
  - clinical-trials
  - repurposing
  - opportunity
---

```{python}
#| echo: false
from dih_models.parameters import *
```

# The Untapped Therapeutic Frontier

### Or: The Parking Lot of Disney World

You think you've explored the world of medicine. In reality, you're standing in the parking lot of Disney World bragging about how much fun the pavement is.

Even after a century of pharmacology, most of the possible beneficial effects of molecules on diseases remain unexplored. Not because biology is constrained, but because clinical trials are slow, expensive, and run by people who think "urgency" is a type of perfume.

Let's do some math. Don't worry, I'll keep it painful but brief.

## The Tiny Sandbox You Play In

Here is the sum total of what humanity considers "medicine" after 5,000 years of civilization:

*   **Prescriptions:** [Over 20,000 products](../references.qmd#fda-approved-products-20k) approved in the U.S. Sounds impressive until you realize most are just "Tylenol, but blue."
*   **Unique Ingredients:** These 20,000 products represent only ~1,300–2,000 unique active ingredients (APIs). That's fewer ingredients than a decent French bakery uses.
*   **Investigational Drugs:** Pipeline analyses suggest [5,000–10,000+ compounds](../references.qmd#bio-clinical-development-2021) have passed Phase I globally.
*   **Safe Stuff:** The FDA GRAS (Generally Recognized as Safe) list contains [~570–700 substances](../references.qmd#fda-gras-list-count).

**Total unique compounds humanity knows are safeish: ~7,000–12,000.**

That's it. That's your toolbox.

## The Target List (Diseases)

*   **Codes:** The ICD-10 has [~14,000 codes](../references.qmd#icd-10-code-count) for ways your body can malfunction.
*   **Real Targets:** Consolidation gives **~1,000 trial-relevant diseases** worth fixing.

## The Math You Are Ignoring

If you take your ~12,000 safe compounds and multiply them by ~1,000 diseases, you get the "Combinatorial Space." This is fancy talk for "stuff we could test tomorrow if we weren't busy filling out forms."

**7,000–12,000 compounds × 1,000 diseases = 7–12 million plausible drug–condition combinations.**

### What You Have Actually Tested

*   **Approved uses:** ~1,500–2,000 unique approved drug–disease uses.
*   **Repurposed uses:** [~30% of drugs gain ≥1 new indication](../references.qmd#drug-repurposing-rate) after initial approval.
*   **Failed trials:** Let's be generous and say you tested 10 times as many things that failed.

**Total tested: ≈15,000–50,000 relationships.**

### The Scorecard

50,000 tested ÷ 7,000,000 possibilities = **0.7%**

**Humanity has explored less than 1% of the theoretically testable drug–disease space.**

You are missing **99.3%** of the picture. It's like reading the first page of *War and Peace* and writing a book report called "It's About a Party."

## Is The Untested Stuff Useful? (Yes, Obviously)

You might argue, "Maybe the other 99% is useless!"

Biology disagrees.

*   **Undrugged Targets:** Mapping 350,000+ clinical trials showed that only [~12% of the human interactome](../references.qmd#clinical-trials-puzzle-interactome) has ever been targeted by drugs. You're ignoring 88% of your own biology.
*   **Polypharmacology:** Drugs are messy. They hit multiple targets. FDA-approved drugs often bind to things you didn't intend them to. This means "side effects" are often "cures for something else" that you just haven't noticed yet.
*   **Network Overlap:** [Diseases cluster on shared biological networks](../references.qmd#disease-network-overlap). A drug for arthritis might cure Alzheimer's. You won't know until you check.

## The Universe is Big. You Are Small.

So far we only counted molecules humanity *already has*. If you look at what's chemically possible, it gets embarrassing.

*   **Chemical Space:** Estimated [10^23 to 10^60](../references.qmd#chemical-space-size) drug-like molecules.
*   **Virtual Libraries:** [ZINC-22 contains tens of billions](../references.qmd#zinc-22-database) of purchasable virtual molecules.
*   **Synthesized:** You have made **<10^(-40)** of possible molecules.

**Tested / Possible = ~10^-20 to 10^-50.**

**Effectively zero.** You haven't even started.

## Why You Are Still Sick

It's not because science is hard. It's because:

1.  **Trials Cost Too Much:** A typical Phase II–III RCT costs **$30–$100M** (Median cost per patient [~$41,000](../references.qmd#trial-cost-41k)). At that price, you only test "sure things."
2.  **Herd Mentality:** Trials overwhelmingly test the same few biological targets due to [preferential attachment dynamics](../references.qmd#preferential-target-attachment). Everyone studies what everyone else is studying because that's how you get grants.
3.  **No Profit:** Most molecules have no patent. No patent = no $100M trial = no approval.
4.  **Neglect:** If you have a rare disease with no market, you don't get a drug. Sorry.

## The Fix

The Oxford RECOVERY Trial (COVID-19) proved that large-scale pragmatic trials can run for [~$500 per patient](../references.qmd#recovery-cost-500) and deliver results in [<100 days](../references.qmd#recovery-trial-100-days-to-cure).

If we automate this via a decentralized FDA (dFDA):

*   We can run **100×–1,000× more trials per year**.
*   Testing **100,000+ drug–condition pairs** becomes realistic.
*   We stop guessing and start exploring the "dark matter" of medical therapeutics.

## Conclusion

> **Humanity has empirically tested less than 1% of the drug–disease relationships that can be tested using existing safe compounds.**
>
> **If you include the larger chemical universe, humanity has explored roughly one-quadrillionth to one-quintillionth of what is possible (10^(-12) to 10^(-50)).**
>
> **The overwhelming majority of therapeutic potential remains untouched. Not because cures are impossible, but because trials are too expensive and too slow.**
>
> **A decentralized, automated pragmatic trial system (a decentralized FDA) is the only route to systematically explore the remaining 99.999…% of medical space.**
